dc.contributorQuispillo Moyota, John Marcos
dc.contributorVinueza Tapia, Diego Renato
dc.creatorPulistar Manosalvas, Jaen Pierre
dc.date.accessioned2021-11-29T21:01:22Z
dc.date.accessioned2022-10-20T19:00:41Z
dc.date.available2021-11-29T21:01:22Z
dc.date.available2022-10-20T19:00:41Z
dc.date.created2021-11-29T21:01:22Z
dc.date.issued2021-04-01
dc.identifierPulistar Manosalvas, Jaen Pierre. (2021). Elaboración de microesferas a base de una matriz polimérica de quitosano cargadas con ácido acetilsalicílico utilizando el método de emulsificación. Escuela Superior Politécnica de Chimborazo. Riobamba.
dc.identifierhttp://dspace.espoch.edu.ec/handle/123456789/14671
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4583517
dc.description.abstractThe objective of the study was to elaborate chitosan microspheres loaded with acetylsalicylic acid, this study was performed in order to obtain prolonged-release pharmaceutical forms that can improve the properties of the tablets such as bioavailability and release of the active principle (AP), reducing the adverse effects caused by them. The elaboration of microspheres was made using the emulsification method, first of all, 9 initial formulations with solutions at different concentrations of the reagents were made. The study was divided into two phases, in the first, the formulation and elaboration of microspheres without loading of pa was carried out, for this, in the first place the parameters of the elaboration method were standardized and thus determine what would be the stirring speed, time and ideal drying method, to obtain microspheres with the desired characteristics, while in the second phase microspheres loaded with AP and later the AP content was determined. and the dissolution profile. The evaluation of morphology and particle size was made by optical microscopy, resulting in microspheres of size less than 1 millimeter, the percentage of encapsulation and release of AP were evaluated following the tests established in the USP for this type of pharmaceutical forms, obtaining an encapsulation percentage of 32.4% and a release percentage of 83.65%, thus complying with all the acceptance criteria established in USP39-NF34. It is concluded that Formulation F5 proved to be the best in all the parameters evaluated, therefore, the microspheres prepared are considered as prolonged-release pharmaceutical forms and with subsequent studies, they could be used in pharmacological treatment. Stability tests are recommended in future research to determine if the microspheres can be applicable to in vitro studies.
dc.languagespa
dc.publisherEscuela Superior Politécnica de Chimborazo
dc.relationUDCTFC;56T00961
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/3.0/ec/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectBIOQUÍMICA
dc.subjectQUITOSANO
dc.subjectMICROESFERAS
dc.subjectFORMAS FARMACEUTICAS DE LIBERACIÓN PROLONGADA
dc.subjectÁCIDO ACETILSALICÍLICO
dc.subjectENCAPSULACIÓN
dc.subjectPRINCIPIO ACTIVO
dc.subjectFORMULACION
dc.titleElaboración de microesferas a base de una matriz polimérica de quitosano cargadas con ácido acetilsalicílico utilizando el método de emulsificación.
dc.typeTesis


Este ítem pertenece a la siguiente institución